E-Learning Center
Join Our Network
OncoFacts

Follow Imedex on Twitter

Register for an upcoming conference!

Phone: +1 (678) 242 0906
registration@imedex.com

World Congress on Gastrointestinal Cancer: Asian Perspectives


register now

World Congress on Gastrointestinal Cancer:
Asian Perspectives

27-28 August 2010

Hong Kong SAR, People's Republic of China

Kowloon Shangri-La Hotel

Who Should Attend
This educational activity is aimed at practicing clinicians, gastroenterologists, hepatologists, surgeons, medical oncologists, radiation oncologists, and clinical researchers who wish to review and update their knowledge and management of cancers of the gastrointestinal tract.

Objectives
After successful completion of this course, attendees should be able to:

  • Discuss evolving multimodality treatment options for patients with esophageal cancer
  • Evaluate the diagnostic tools and endoscopic techniques used to detect and manage early gastric cancer
  • Select the most appropriate therapeutic strategy for gastric cancer
  • Integrate advances in systemic and local therapies into clinical practice to treat hepatobiliary tumors
  • Summarize new and emerging treatment options for pancreatic cancer
  • Improve the outcomes of patients with localized colorectal disease by employing most favorable adjuvant therapy
  • Comment on the role of cytotoxic treatment regimens, angiogenesis inhibitors and EGFR inhibitors in advanced or metastatic colorectal cancer
  • Assess the clinical implications of using molecular markers as screening and prognostic tools for colorectal cancer
  • Review the most clinically relevant data recently presented regarding upper GI and colorectal cancer management
  • Comment on surgical techniques used to treat various gastrointestinal cancers

Alex Y. Chang, MD
Johns Hopkins Singapore International
Medical Centre
Singapore, Singapore

Ann-Lii Cheng, MD, PhD
National Taiwan University Hospital
Taipei, Taiwan

Mario Dicato, MD
Luxembourg Medical Center
Luxembourg, Luxembourg

Jin Li, PhD
Fudan University Cancer Hospital
Shanghai, China

Atsushi Ohtsu, MD, PhD
National Cancer Center Hospital East
Kashiwa, Japan

Virote Sriuranpong, MD, PhD
Chulalongkorn University
Bangkok, Thailand

Han-Hwang Yang, MD, PhD
Seoul National University Hospital
Seoul, South Korea

John R. Zalcberg, MD, PhD
Peter MacCallum Cancer Centre
Melbourne, Australia

 

Anthony TC Chan, MD, FRCP
Chinese University of Hong Kong
Hong Kong SAR,
People’s Republic of China

Alex Y. Chang, MD
Johns Hopkins Singapore
International Medical Centre
Singapore, Singapore

Ke-Neng Chen, MD, PhD
Peking University School of Oncology
Bejing, China

Ann-Lii Cheng, MD, PhD
National Taiwan University Hospital
Taipei, Taiwan

Jae-Yong Cho, MD, PhD
Yonsei University
Gangnam Severance Hospital
Seoul, South Korea

Michael Choti, MD, MBA
Johns Hopkins University
School of Medicine
Baltimore, Maryland, United States

Mario Dicato, MD
Luxembourg Medical Center
Luxembourg, Luxembourg

Chiun Hsu, MD, PhD
National Taiwan University Hospital
Taipei, Taiwan

Hwoon-Yong Jung, MD, PhD, AGAF
University of Ulsan College of Medicine
Asan Medical Center
Seoul, South Korea

Yoon-Koo Kang, MD, PhD
University of Ulsan College of Medicine
Asan Medical Center
Seoul, South Korea

Jee Hyun Kim, MD, PhD
Seoul National University
College of Medicine
Seongnam, South Korea

Jong Hoon Kim, MD, PhD
University of Ulsan College of Medicine
Asan Medical Center
Seoul, South Korea

Tae-Won Kim, MD, PhD
University of Ulsan College of Medicine
Asan Medical Center
Seoul, South Korea

Wai-Keung Leung, MD
Union Hospital
Hong Kong SAR
People’s Republic of China

Jin Li, PhD
Fudan University Cancer Hospital
Shanghai, China

Brigette, Ma, MBBS, FRACP
Chinese University of Hong Kong
Hong Kong SAR
People’s Republic of China

Atsushi Ohtsu, MD, PhD
National Center Hospital East
Kashiwa, Japan

Ronnie Poon, MD
University of Hong Kong
Queen Mary Hospital
Hong Kong SAR
People’s Republic of China

Taroh Satoh, MD
Kinki University School of Medicine
Osakasayama-Shi, Japan

Jinsil Seong, MD, PhD
Yonsei University Medical College
Seoul, South Korea

Ho-Young Song, MD, PhD
University of Ulsan College of Medicine
Asan Medical Center
Seoul, South Korea

Virote Sriuranpong, MD, PhD
Chulalongkorn University
The King Chulalongkorn
Memorial Hospital
Bangkok, Thailand

Peter Man-Lung Teo, MD
Comprehensive Oncology Centre
Hong Kong SAR
People’s Republic of China

Sumitra Thongprasert, MD
Maharaj Nakorn Chiangmai Hospital
Chiangmai, Thailand

Eric Van Cutsem, MD, PhD
University Hospital Gasthuisberg
Leuven, Belgium

Jaw-Yuan Wang, MD, PhD
Kaohsiung Medical University Hospital
Kaohsiung, Taiwan

Han-Kwang Yang, MD, PhD
Seoul National University Hospital
Seoul, South Korea

Winnie Yeo, MD, FRCP, FHKAM
Prince of Wales Hospital
The Chinese University of Hong Kong
Hong Kong SAR
People’s Republic of China

Xiao-Yu Yin, MD, PhD
The First Affiliated Hospital
Sun Yat-Sen University
Guangshou, China

Wai Key Yuen, MBBS, FRCS, FRACS, FACS, FHKAM
Queen Mary Hospital
Hong Kong SAR
People’s Republic of China

John R. Zalcberg, MD, PhD
Peter MacCallum Cancer Institute
Melbourne, Australia

Friday, 27 August 2010

8:00
Welcome and introduction
Eric Van Cutsem, MD, PhD and
Yoon-Koo Kang, MD, PhD

Session I: Epidemiology

8:05
Epidemiology and causes of GI cancer
Wai-Keung Leung, MD

Session II: Esophageal cancer
Moderator: Virote Sriuranpong, MD, PhD

8:25
Surgery for esophageal cancer
Ke-Neng Chen, MD, PhD

8:45
Multimodality treatment of esophageal cancer
Jong Hoon Kim, MD, PhD

9:05
The role of retrievable stents in malignant esophageal strictures
Ho-Young Song, MD, PhD

9:25
Case discussion on the management of esophageal cancer
Moderator: Virote Sriuranpong, MD, PhD
Panel: Jong Hoon Kim, MD, PhD, Ho-Young Song, MD, PhD, and Ke-Neng Chen, MD, PhD

9:50
Break and poster viewing

Session III: Gastric cancer
Moderator: Yoon-Koo Kang, MD, PhD

10:15
Diagnosis and endoscopic management of early gastric cancer
Hwoon-Yong Jung, MD, PhD, AGAF

10:40 Surgical management of gastric cancer
Han-Kwang Yang, MD, PhD

11:00
Chemotherapy of advanced gastric cancer
Winnie Yeo, MD, FRCP, FHKAM

11:20 Selected abstract presentation on gastric cancer (II): QOL analysis of ToGA study
Taroh Satoh, MD

11:35
Selected abstract presentation on gastric cancer (III): AVAGAST trial
Atsushi Ohtsu, MD, PhD

11:50
Case discussion: Early disease case - endoscopic resection vs laparoscopic resection vs open surgery, advanced disease case - neoadjuvant chemo vs adjuvant chemo
Moderator: Yoon-Koo Kang, MD, PhD
Panel: Eric Van Cutsem, MD, PhD, Hwoon-Yong Jung, MD, PhD, AGAF, Han-Kwang Yang, MD, PhD, Winnie Yeo, MD, FRCP, FHKAM, and Atsushi Ohtsu, MD, PhD

12:15
General session adjourns

12:40
Lunch Symposium
Targeting to improve outcomes in advanced neuroendocrine tumors, gastric cancer and hepatocellular carcinoma: Clinical impact of mTOR therapy
Supported by Novartis Oncology

14:10
Symposium adjourns

Session IV: Hepatobiliary tumors
Supported by sanofi-aventis
Moderator: Anthony TC Chan, MD, FRCP

14:30
Introduction
Sumitra Thongprasert, MD

14:40
Surgical & non-surgical management of HCC
Ronnie Poon, MD

15:00
Radiation therapy for HCC
Jinsil Seong, MD, PhD

15:20
Chemotherapy as a foundation in the treatment of HCC
Xiao-Yu Yin, MD, PhD

15:40
Targeted therapy: Future development in HCC
Ann-Lii Cheng, MD, PhD

16:00
Case discussion
Moderator: Ann-Lii Cheng, MD, PhD
Panel: Verote Sriuranpong, MD, PhD and Xiao-Yu Yin, MD, PhD
Case 1: Chiun Hsu, MD, PhD
Case 2: Jae-Yong Cho, MD, PhD

16:25
Discussion

16:30 Break

Session V: Pancreatic cancer
Moderator: Alex Y. Chang, MD

16:50
Surgical management of pancreatic cancer
Wai Key Yuen, MBBS, FRCS, FRACS, FACS, FHKAM

17:10
Multimodality treatment
Jin Li, PhD

17:30
Case discussion on the management of pancreatic cancer
Moderator: Jin Li, PhD
Panel: Alex Y. Chang, MD and Wai Key Yuen, MBBS, FRCS, FRACS, FACS, FHKAM

17:55
Closing remarks

18:00
Adjourn


Saturday, 28 August 2010

8:30
Welcome and introduction
Eric Van Cutsem, MD, PhD and Yoon-Koo Kang, MD, PhD

Session VI: Localized colorectal cancer
Moderator: John R. Zalcberg, MD, PhD

8:35
Surgical management of rectal cancer
Michael Choti, MD, MBA

8:55
Adjuvant therapy for colorectal cancer
Tae-Won Kim, MD, PhD

Session VII:
Advanced colorectal cancer
Moderator: Anthony TC Chan, MD, FRCP

9:15
What is the optimal cytotoxic regimen in advanced colorectal cancer?
Jin Li, PhD

9:35
Predictive molecular markers in colorectal cancer
Jee Hyun Kim, MD, PhD

9:55
EGFR inhibitors in metastatic colorectal cancer
Peter Man-Lung Teo, MD

10:15
Angiogenesis inhibitors in metastatic colorectal cancer
Brigette Ma, MBBS, FRACP

10:35
Optimal neo-adjuvant chemotherapy for the management of liver metastases
Jaw-Yuan Wang, MD, PhD

10:55
Break

Session VIII: Management of mCRC patients in clinical practice: Case discussion
Supported by Merck Serono

11:10
Personalizing treatment: A new standard for prolonging overall survival in mCRC
Eric Van Cutsem, MD, PhD

11:25
Case 1: Cetuximab brings curative treatment possible
Kefeng Ding, MD

Case 2: A case of large bilateral synchronous colorectal liver metastases
B. K. Smruti, MD

Case 3: A young man with aggressive advanced colorectal cancer
Thomas Yau, MD

11:55
Discussion
Moderator: Siu Pin Choo, MD
Panel: Eric Van Cutsem, MD, PhD

Session IX: Highlights from 2010 in GI cancer management
Moderator: Eric Van Cutsem, MD, PhD

12:15
Biological markers in GI cancer
Mario Dicato, MD

12:35
Emerging targets in gastric cancer
John R. Zalcberg, MD, PhD

12:55
Highlights from ASCO and World Congress on upper gastrointestinal cancer
Eric Van Cutsem, MD, PhD

13:15
Closing remarks

13:20
Adjourn

register now

Registration Fees

Discounted.....................................$225 USD (If payment received by 8 July 2010)
Regular..........................................$275 USD (If payment received by 19 August 2010)
Full/Onsite*....................................$325 USD (If payment received after 19 August 2010)
Nurses/Residents/Students*............$50 USD (*proof of eligibility must accompany registration and will be verified)

NOTE: Registrants that pay with American Express will be charged in the USD equivalent which may incur additional charges. This is a policy of American Express. Foreign exchange rate information may be found at www.oanda.com. After 19 August 2010 only credit card payments will be accepted for pre-registration.

To pre-register, registration and payment must be received no later than Thursday, 19 August 2010. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure the program is being held as scheduled and to confirm that the meeting is not full.

For registration fees to be refunded, written notice of cancellation must be received at Imedex no later than 19 August 2010. The amount of registration fees remitted, minus a $75 administrative charge, will be refunded after the Congress. Substitutions are accepted with written notification. No refunds will be made if notice is received after 19 August 2010.

Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this Congress should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The agenda content is subject to change without notice.

Conference Location and Registration

Kowloon Shangri-La
64 Mody Road
Tsim Sha Tsui East
Kowloon, Hong Kong SAR
Tel: +852 2721 2111
Fax: +852 2723 8686
Web: http://www.shangri-la.com

The Registration and Information Desk will be staffed:
Friday, 27 August 2010 7:00 – 18:00
Saturday, 28 August 2010 7:30 – 13:00

 

Kowloon Shangri-La
64 Mody Road
Tsim Sha Tsui East
Kowloon, Hong Kong SAR
Tel: +852 2721 2111
Fax: +852 2723 8686
Web: http://www.shangri-la.com

Hotel Description

The deluxe harbour-front Kowloon Shangri-La is located at the heart of the renowned shopping and entertainment district of Kowloon, close to all major public transportation routes. As one of the quintessential Kowloon hotels in Hong Kong, Kowloon Shangri-La offers guests some of the most spacious rooms in the city, with floor-to-ceiling bay windows with the panoramic view of the Victoria Harbour and Hong Kong Island.

Kowloon Shangri-La’s distinguished restaurants have elevated dining to an art form, successfully winning the hearts and seducing the palates of the most discriminating diners. The hotel’s 24-hour Health Club takes care of physical fitness and relaxation, and its state-of-the art conference facilities, supported by attentive staff and events management specialists, make every event and occasion the most memorable.

For the convenience of attendees, a room block with a limited number of Superior City rooms has been reserved at the discounted group rate of HK$1,500.00 (single occupancy) and HK$1,700.00 (double occupancy), plus 10% service charge per room per night. This room rate is inclusive of daily buffet breakfast(s) per occupancy; one for single occupancy and two for double occupancy. This limited number of discounted rooms will be available until 3 August 2010. This discounted rate is not guaranteed outside the conference dates. Reservations received after 3 August 2010 or after the room block has been filled (whichever comes first) are subject to availability and prevailing hotel rates.

You can make your booking directly on the hotel’s website using the Group Code:
1) Go to the Shangri-La website: http://www.shangri-la.com/reservations/booking/en/index.aspx?hid=KSL&group_code=IME240810A&check_in=20100824&check_out=2010083
2) Enter all the necessary stay requirements like check-in date, check-out date, number of rooms, adults and children.
3) Under the “Special Rate” area, select “Group Code” and enter the Group Code: IME240810A
4) Click the Check Availability button to continue.
5) If all the search criteria are correct and rooms are still available for the group, the group rate will be returned in the availability search result. Simply follow the on-screen instructions to complete the online booking.

Reservation requests received after 3 August 2010 may not be guaranteed the group rate.

Letter From the Chair

It is our pleasure to invite you to attend the
4th World Congress on Gastrointestinal Cancer: Asian Perspectives
, 27-28 August
2010 in Hong Kong.

This two-day scientific meeting will provide state of the art information on the multi-disciplinary management of patients with gastrointestinal cancer including surgical management options, current trends and controversies, and significant developments in the field. Case discussions in each session bring clinical reality to the agenda, translating the didactic presentations into practical application. Guided by the expert international faculty, you will update your knowledge in the field, confirm your current practice and receive valuable take-home information that will allow you to optimize care of your patients.

This year, we will also take a closer look at some of the emerging studies being done in the field, with presentations of selected abstracts, offering opportunities for researchers to interact with colleagues and share their endeavors with the healthcare community. We invite you to participate this year by submitting an abstract of your work to be considered for presentation.

We know you will find the World Congress on Gastrointestinal Cancer: Asian Perspectives to be a valuable, world-class educational event, and we hope you will join us in the wonderfully dynamic city of Hong Kong!

Sincerely,

Chairs:
Eric Van Cutsem, MD, PhD
Yoon-Koo Kang, MD, PhD

 

 

 

PDF Announcement

 


Chairs:

Eric Van Cutsem, MD, PHD
University Hospital Gasthuisberg
Leuven, Belgium

Yoon-Koo Kang, MD, PHD
Asan Medical Center
Seoul, South Korea

Local Chair:

Anthony TC Chan, MD, FRCP
Chinese University of Hong Kong
Hong Kong SAR, People’s Republic of China

Organizer

Imedex
11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
T: +1 770.751.7332
F: +1 770.751.7334
E: meetings@imedex.com
W: www.imedex.com

Important Dates

Discounted Registration Deadline
Thursday, 8 July 2010

Abstract Notifications Mailed
Tuesday, 22 June 2010

Abstract Presenter Registration Deadline
Thursday, 15 July 2010

Regular Registration Deadline
Thursday, 19 August 2010

Presentation Dates
27-28 August 2010

 

 

The following companies have provided support for this Congress:

Silver:

Merck Serono

Novartis Oncology

 

Corporate:

sanofi aventis

 

Several options are available to companies interested in supporting this Congress.
For more information, please contact Imedex at +1 770.751.7332, or by email at cme@imedex.com.

Space is available to companies interested in participating in this Congress through exhibition.
For more information, please contact Cori Gunter at +1 678.242.0712, or by email at c.gunter@imedex.com.

Targeting to Improve Outcomes in Advanced Neuroendocrine
Tumors, Gastric Cancer and Hepatocellular Carcinoma:
Clinical Impact of mTOR Therapy

Friday, August 27, 2010
12:40 - 14:10

Lunch Symposium is supported by
Novartis Oncology

Faculty:

Eric Van Cutsem, MD, PhD – Chair
University Hospital Gasthuisberg
Leuven, Belgium

Atsushi Ohtsu, MD
National Cancer Center
Hospital East
Kashiwa, Japan

Li Tzong Chen, MD, PhD
National Health Research Institute
Taipei, Taiwan

Young Suk Park, MD, PhD
Samsung Medical Center
Seoul, Korea

Agenda:

12.40 -12.45
Welcome, Overview and Objectives
Eric Van Cutsem, MD, PhD

12.45 -13.05
mTOR as an Emerging Therapy in the Treatment of Advanced Neuroendocrine Tumors
Young Suk Park, MD, PhD

13.05 -13.25
Investigating the mTOR Pathway in the Treatment of Gastric Cancer
Atsushi Ohtsu, MD

13.25 -13.45
An Examination of mTOR as A Potential Target in the Treatment of Hepatocellular Carcinoma
Li Tzong Chen, MD

13.45 -14.05
Discussion All

14.05 -14.10
Closing Remarks and Conclusions
Eric Van Cutsem, MD, PhD

 

An independent satellite symposium held in conjunction with 4th World Congress on Gastrointestinal Cancer: Asian Perspectives.  This presentation is not sponsored or endorsed by 4th World Congress on Gastrointestinal Cancer: Asian Perspectives